FDA Issues National Priority Vouchers for Three Psychedelics Under Trump Mental Health Initiative
AI SummaryABC News4h agoUnited States
Image: ABC News
β’The FDA announced it will issue national priority vouchers for three psychedelic drugs next week, marking the first time the agency has fast-tracked any psychedelics for review under Trump's executive order on mental health reform.
β’The vouchers can compress FDA review timelines from several months to just weeks, according to FDA Commissioner Marty Makary, if the drugs align with national priorities.
β’
Trump's order directs $50 million in federal funding to states developing psychedelic treatment programs and establishes a federal-state partnership for technical assistance and data sharing.
β’The Department of Veterans Affairs is participating in at least five clinical trials of psychedelic drugs across New York, California, and Oregon to treat PTSD in military personnel and veterans.
β’ President Trump signed an executive order directing federal regulators to fast-track FDA review of psychedelic drugs including psilocybin and ibogaine for treating depression, anxiety, and PTSD.
β’ The order allocates $50 million in federal funds to states implementing or developing psychedelic treatment programs as part of a federal-state partnership initiative.
β’ Trump highlighted that over 14 million American adults have serious mental illness, with approximately 8 million on prescription medication, framing psychedelics as addressing a national mental health crisis including suicide prevention.
β’ The FDA announced the first ibogaine investigational new drug application as part of Trump's mental health executive order accelerating psychedelic drug approvals and research pathways.
β’ HHS will coordinate with the FDA and DEA to expedite research approval and clinical trial access for emerging mental health treatments under strict medical supervision and scientific oversight.
β’ The initiative specifically targets treatment-resistant conditions and addresses mental health needs among veterans and patients who have not responded to conventional therapies.
β’ President issues executive order on April 18, 2026, to speed medical treatments for serious mental illness using psychedelic drugs including ibogaine compounds.
β’ Order highlights clinical studies showing potential for patients with persistent conditions unresponsive to standard therapies.
β’ Directs federal agencies to prioritize research, approvals, and access to innovative mental health interventions nationwide.
β’ President Donald Trump announced Dr. Jennifer Shuford, Texas' top public health official and infectious disease physician, as his nominee for CDC chief medical officer on Thursday via Truth Social.
β’ Shuford oversaw the country's largest measles outbreak in 30 years; other nominees include Dr. Erica Schwartz as CDC director, Sean Slovenski as deputy director and COO, and Dr. Sara Brenner as senior counselor to HHS Secretary Robert F. Kennedy, Jr.
β’ The appointments aim to reshape CDC leadership amid ongoing public health challenges in the US.
β’ CDC reports rotavirus circulating at high levels nationwide, with 73.8% of US children vaccinated against the highly contagious virus causing severe diarrhea in infants.
β’ Health experts attribute the late-season surge to vaccine hesitancy, noting the Trump administration's past efforts to remove rotavirus vaccine from childhood schedules.
β’ Cases are life-threatening for kids, prompting warnings as emergency room visits remain elevated beyond typical seasonal peaks.
β’ CDC data indicates 71 per 100,000 emergency room visits for tick bites in the most recent week, highest in Northeast followed by Midwest, Southeast, West, and South Central.
β’ Rising tick activity signals increased Lyme disease and other vector-borne risks as warmer weather extends season.
β’ Public health experts warn of prevention needs amid Northeast ER surge.
β’ FDA ties multistate E. coli outbreak sickening multiple individuals to cheese made with unpasteurized raw milk.
β’ Highlights risks of raw dairy products in public health alerts.
β’ Investigation ongoing to prevent further cases amid rising food safety concerns.
β’ CDC data shows 3.6 million US births in 2025, a 1% decline from 2024, with fertility rate at 53.1 births per 1,000 women ages 15-44, down 23% since 2007.
β’ Trump administration downplays contraception in Title X grants, mentioning it once as overprescribed with side effects, amid efforts to reverse birth decline.
β’ High maternal mortality of 17.9 deaths per 100,000 live births in 2024, with 4 in 5 pregnancy deaths preventable, contrasts lower risks of contraception.
β’ California has recorded at least 40 measles cases so far in 2026, surpassing the 25 cases of all 2025 and the highest annual total since 73 in 2019.
β’ San Francisco confirmed its first measles case in 7 years in an unvaccinated infant under 1 year old, infected during international travel and recovering at home.
β’ Outbreaks linked to unvaccinated travelers from South Carolina's 1,000-case surge and other states, with exposures at Sacramento preschools, San Bernardino, San Diego ER, and Bay Area sites.
β’ HHS launched the $4 Million KidneyX EMPOWER Prize Challenge on April 15, 2026, to advance living kidney donation and patient-centered health technologies.
β’ The initiative aims to spur innovation in kidney care through science and programs improving American health outcomes.
β’ This effort addresses critical needs in organ transplantation, potentially increasing donation rates and access to treatments.
β’ Between 2009 and 2023, the US recorded at least 402 tetanus cases with 37 deaths, primarily among those unvaccinated or overdue for boosters.
β’ None of the fatalities involved individuals with three or more doses of tetanus-containing vaccine, highlighting booster importance every 10 years.
β’ The analysis underscores ongoing risks from this bacteria despite effective vaccines, with many cases in people lacking full primary series.